Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 7, 2008 - Issue 2
Submit an article Journal homepage
345
Views
29
CrossRef citations to date
0
Altmetric
Review

Antiepileptic drugs as human teratogens

Mervyn J Eadie Emeritus Professor of Clinical Neurology and Neuropharmacology, University of Queensland, Honorary Consultant Neurologist Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia 4029, Australia +61 7 38311704; +61 7 38325608; [email protected]
, AO MD PhD FRCP Ed FRACP
Pages 195-209 | Published online: 06 Mar 2008

Bibliography

  • Von Muller-Kuppers M. Zur Frage der Fruchtschadigung in der Schwangerschaft durch Einnahme von Antiepileptica. Acta Paedopsychiatrica 1963;30:401-5
  • Janz D, Fuchs U. Are anti-epileptic drugs harmful when given during pregnancy? Ger Med Monthly 1964;9:20-2
  • Meadow SR. Congenital abnormalities and anticonvulsant drugs. Proc Royal Soc Med 1970;63:48-9
  • Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;2:839-43
  • Fedrick J. Epilepsy and pregnancy: a report from the Oxford record linkage study. BMJ 1973;2:441-8
  • Janz D. The teratogenic risk of antiepileptic drugs. Epilepsia 1975;16:159-69
  • Nakane Y, Okuma T, Takahashi R, et al. Multi-institutional study on the tertatogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980;21:663-80
  • Dravet C, Julian C, Legras C, et al. Epilepsy, antiepileptic drugs, and malfoprmations in children of women with epilepsy: a French prospective cohort study. Neurology 1992;42 Suppl 5:75-82
  • Kaneko S, Otani K, Kondo T, et al. Malformations in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 1992;42 Suppl 5:68-74
  • Samrén EB, Van Duijn CM, Koch S, et al. Maternal use of antieptileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-90
  • Olafsson E, Hallgrimsson JT, Hauser WA, et al. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998;39:887-92
  • Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6
  • Fonager K, Larsen H, Pedersen L, Sorensen HT. Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand 2000;101:289-94
  • Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-8
  • Fried S, Kozer E, Nulman I, et al. Malformation rates in children of women with untreated epilepsy. Drug Saf 2004;27:197-202
  • Stoler JM. Maternal antiepileptic drug use and effects on fetal development. Curr Opin Pediatr 2001;13:566-71
  • Hart YM. Should first-line treatment of epilepsy differ for males and females? J Roy Coll Phys Edinb 2003;33(Suppl 11):11-21
  • Kaplan PW. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 2004;63(Suppl 4):S13-23
  • Perruca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 2005;4:781-6
  • Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 2006;22:214-26
  • Dolk H, McElhattan. Assessing epidemiological evidence for the teratogenic effect of anticonvulsant medications. J Med Genet 2002;39:243-4
  • Reefguis J, De Jong-van den Berg LTW, Cornel MC. The use of birth defect registries for etiological research: a review. Comm Genet 2002;5:13-32
  • Tomson T, Battino D. Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol 2005;18:135-40
  • Kallen BAJ. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom 2005;45:44-51
  • Vajda F, O'Brien T, Hitchcock A, et al. The Australian pregnancy register of antiepileptic drugs – aspects of data collection and analysis. J Clin Neurosci 2007;14:936-42.
  • Carlin JB, Ryan L, Harvey EA, Holmes LB. Anticonvulsant teratogenesis 4: inter-rater agreement in assessing minor physical features related to anticonvulsant therapy. Teratology 2000;62:406-12
  • Meador KJ. Neurodevelopmental effects of antiepileptic drugs. Curr Neurol Neurosci Rep 2002;4:373-8
  • Holmes LB, Rosenberger PB, Harvey EA, et al. Intelligence and physical features of children of women with epilepsy. Teratology 2000;61:196-202
  • Battino D. Assessment of teratogenic risk. Epilepsy Res 2001;45:171-3
  • Yerby M. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003;61(Suppl 2):S23-6
  • Hauser WA, Tomson T. Lamotrigine and the risk of malformations in pregnancy. Neurology 2006;66:153
  • Al-Yaman F, Bryant M, Sargeant H. Australia's Children: Their Health and Wellbeing. Canberra: Australian Institute of Welfare and Health; 2002
  • Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9
  • Vajda F, O'Brien T, Hitchcock A, et al. The internal control group in a register of antiepileptic drug use in pregnancy. J Clin Neurosci 2008;15(1):29-35
  • Vajda FE, O'Brien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenesis: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004;11:854-8
  • Steegers-Theunissen RPM, Renier WO, Borm GF, et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study. Epilepsy Res 1994;18:261-9
  • German J, Kowal A, Ehlers KH. Trimethadione and human teratogenesis. Teratology 1970;3:349-62
  • Wheatly D. Drugs in pregnancy survey. Practitioner 1963;191:775-80
  • Nelson MN, Forfar IO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. BMJ 1971;1:523-7
  • Arpino C, Brescianini S, Robert E, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000;41:1436-43
  • Holmes LB, Wyszynski DF, Lieberman E; for the AED Pregnancy Registry. The AED (antiepileptic drug) pregnancy registry. A 6-year experience. Arch Neurol 2004;61:673-8
  • Kjaer D, Horvath-Puho E, Christensen J, et al. Use of phenytoin, phenobarbital, or diazepam and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 2007;16:181-8
  • Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1976;1:272-5
  • Barrett C, Richens A. Epilepsy and pregnancy: report of an Epilepsy Research Foundation workshop. Epilepsy Res 2003;52:147-87
  • Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr 1975;87:285-90
  • Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-7
  • Matalon S, Schectman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 2002;16:9-17
  • Morrow J, Russell A, Guthrie E, et al. Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;71:193-8
  • Dalens B, Raynaud EJ, Gaulme J. Teratogenicity of valproic acid. J Pediatr 1980;97:332-3
  • Clay SA, McVie R, Chen H. Possible teratogenic effect of valproic acid. J Pediatr 1981;99:828
  • Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982;2:937
  • Editorial: Valproate and malformations. Lancet 1982;2:1313-4
  • Lindhout D, Schmidt D. In-utero exposure to valproate and neural-tube defects. Lancet 1986;2:1392-3
  • Duncan S, Mercho S, Lopes-Cended I, et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001;42:750-3
  • Genton P, Semah F, Trinka E. Valproic acid in epilepsy. Pregnancy-related issues. Drug Saf 2006;29:1-21
  • Duncan S. Teratogenesis of sodium valproate. Curr Opin Neurol 2007;20:175-80
  • Kozma C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic anbnormalities and a review of the literature. Am J Med Genet 2001;98:168-75
  • Winter RM, Donnai D, Burn J, Tucker SM. Fetal valproate syndrome: is there a recognizable phenotype? J Med Genet 1987;24:692-5
  • Witters I, Van Assche F, Fryns JP. Nuchal edema as the first sign of fetal valproate syndrome. Perinatal Diagn 2002;22:834-5
  • Wide K, Windbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr Scand 2004;93:174-6
  • Wyazynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-5
  • Meador KJ, Baker JA, Finnell RH, et al. In utero fetal drug exposure. Fetal death and malformations. Neurology 2006;67:407-12
  • Koren G, Nava-Ocampo AA, Sussman R, Nulman I. Major malformations with valproic acid. Can Fam Physician 2006;52:441-7
  • Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58
  • Samren EB, Van Duijn CM, Christiaens GCML, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-46
  • Omtzigt JGC, Los FJ, Grobbee DE, et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(Suppl 5):119-25
  • Vajda F, O'Brien T, Graham J, et al. Pregnancies in women with epilepsy. J Roy Coll Phys Edinb 2006;36:201-7
  • Eadie MJ, Vajda FJ. Should valproate be taken during pregnancy? Ther Clin Risk Manage 2005;1:21-6
  • Sabers A, Dam M, A-Rogvi-Hansen B, et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004;109:9-13
  • Tennis P, Eldridge RR; The International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002;43:1161-7
  • Cunnington M, Tennis P; The International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-60
  • Cunnington M, Ferber S, Quatery G; The International Lamotrigine Pregnancy Registry. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007;48:1207-10
  • Palmieri C, Canger R. Teratogenic potential of the newer antiepileptic drugs. What is known and how should this influence prescribing? CNS Drugs 2002;16:755-64
  • Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in the offspring. Neurology 2005;64:1874-8
  • Mieschenguiser R, D'Giano CH, Ferraro SM. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 2004;5:163-7
  • Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701
  • Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003;4:310-7
  • Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy register. Neurology 2006;67:1876-9
  • Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 2003;4:447-8
  • Kondo T, Kaneko S, Amano Y, Egawa I. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 1996;37:1242-4
  • Lindhout D, Hoppener RJEA, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77-83
  • Richmond JR, Krishanmoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004;190:371-9
  • Adab N, Kinu U, Ayres J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
  • Eriksson K, Viinikainen K, Monkkonen A, et al. Children exposed to valproate in utero - population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005;65:189-200
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32
  • Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995;274:1518-25
  • Kaindl AM, Asimiadou S, Manthey D, et al. Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006;63:399-413
  • Dean JCS, Hailey H, Moore SJ, et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-8
  • Vinten J, Adab N, Kini U, et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005;64:949-54
  • Diav-Citrin O, Schectman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 2001;57:321-4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.